AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CRES.BA
ACCE-researched

Cresud SA (CRES.BA) fair value

Industrials · Conglomerates · BYMA · Argentina
ARS 1888.00+5.83%
Market cap ARS 1.27TNext earnings 2026-11-10Updated Oct 24, 2026 · valuation updating
Add earnings to calendarGoogle
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionCresud SA (CRES.BA)
Fair value
Not available
ACCE price target
ARS 2200
Rating
Not rated
Horizon
12 months
ACCE price target published on 20 Oct 2026, 02:20 CEST.
Price used: ARS 1888 at the close on 23 Oct 2026, 22:00 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
58
out of 100
P/E
6.7x
forward 3.6x
1-year return
+29.0%
Dividend yield
0.00%

Cresud SA in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Cresud is an Argentine agribusiness and real estate conglomerate, running farmland, crop and cattle operations alongside urban property development and hotels, with its Dolphin and IRSA-linked holdings giving it exposure well beyond the farm gate. The structural case rests on that land base and a diversified mix that cushions any single commodity cycle, which is reflected in a 40.6% gross margin and a 16.9% operating margin. Revenue grew 8.3% and return on equity sits at 12.2%, while the trailing P/E of 6.8 looks cheap against the market. The forward P/E of 1029.1 is a red flag, not a bargain: it implies earnings collapse or a sharp swing in the forecast base, and that needs explaining before anyone leans on the trailing multiple. Worth a deeper look to reconcile the trailing and forward earnings picture and to assess how much of the reported profitability survives Argentina's currency and inflation distortions.

AI-assisted·How I use AIWritten Oct 20, 2026

Next results

Nov 10, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CRES.BA's valuation models land
Price
ARS 1888.00
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+1.5%
1 month
-7.5%
3 months
+6.3%
6 months
+13.7%
YTD
-1.6%
1 year
+29.0%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 02:20 CESTACCE price targetARS 2200first publicationARS 1842

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in ARS. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CRES.BA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth40Value52Quality70Momentum68Total58
Valuation
Trailing P/E
6.7x
Forward P/E
3.6x
PEG
no data
P/B
0.99x
EV / Revenue
2.1x
Book value/sh
ARS 2057.90
Enterprise value
ARS 2.84T
Profitability
ROE
12.2%
FCF yield
0.47%
ROIC
4.2%
Health and risk
Debt / equity
1.39
Dividend yield
0.00%
Beta
-0.06

Price

+29.0% · 1Y

Ask anything about CRES.BA

Answered from Cresud SA fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 5.2x6.7xhigh 58.8x
ROEbetter than 100% of peers
low 3%12%high 12%
Div yieldbetter than 33% of peers
low 0.0%0.0%high 4.7%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CRES.BA Cresud SAARS 1888.00--6.7x12.2%7058
SK.SN Sigdo KoppersCLP 1598.70--14.1x10.7%4767
9008.T Keio Corporation¥759.10--10.5x9.8%5058
ANTARCHILE.SN Antar ChileCLP 7295.50--5.2x8.2%3959
9142.T Kyushu Railway Company¥3421.00--11.6x9.3%6254
PFGRUPOARG.CL Grupo Argos preferredCOP 15920.00--55.8x2.9%6173
THERMAX.NS Thermax Limited₹3161.30--58.8x-4929

Sector report card

Where CRES.BA ranks against its sector peers on each metric.

Computing percentiles…